Biohaven (BHVN) Earnings Date & Reports

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

BHVN is expected to report earnings to fall 21.60% to -61 cents per share on November 17

Q3'26

Est.

$-0.61

Q2'26

Missed

by $0.03

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.28

Q3'25

Beat

by $0.24

The last earnings report on August 10 showed earnings per share of -77 cents, missing the estimate of -75 cents. With 2.86M shares outstanding, the current market capitalization sits at 1.92B.

View a ticker or compare two or three

BHVN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BHVN